Relapse prevention with levomilnacipran ER in adults with major depressive disorder: A multicenter, randomized, double‐blind, placebo‐controlled study

BACKGROUND: Levomilnacipran extended release (ER) is a serotonin and norepinephrine reuptake inhibitor approved for major depressive disorder (MDD) in adults. This study was designed to evaluate relapse prevention with levomilnacipran ER in patients with MDD. METHODS: Patients (≥18 years) with MDD (...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Depress Anxiety
Hlavní autoři: Durgam, Suresh, Chen, Changzheng, Migliore, Raffaele, Prakash, Chandran, Thase, Michael E.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2019
Témata:
Research Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6590342/
https://ncbi.nlm.nih.gov/pubmed/30675739
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/da.22872
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky